The age association reflects broader trends of increased infection severity in older populations, while the C5 inhibitor link may relate to severe bacterial risks (e.g., meningococcal infections) (Ladhani et al., 2019) or differences in patient demographics and exposure duration. Here, C5 is linked to infection.